JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A3919 Vilazodone Hydrochloride

Summary: Combined SSRI and 5-HT1A receptor partial agonist

≥23.9 mg/mL
BA2539 m-PEG11-Amine

Summary: m-PEG11-Amino is a degradable (cleavable) linker for the synthesis of antibody-coupled active molecules (ADCs).
BA6503 PD0325901-O-C2-dioxolane

Summary: PD0325901-O-C2-dioxolane contains an inhibitor PD0325901 major fraction.
SL1025 Glutaryl carnitine-d3 HCl

Summary: A stable isotope deuterated compound of Glutaryl carnitine HCl
A4148 NVP-BSK805 2HCl

Target: JAK

Summary: JAK2 inhibitor

≥30.8 mg/mL
A4106 Scriptaid
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor,novel and cell-permeable

insoluble in H2O; ≥13.1 mg/mL
A4130 ENMD-2076

Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-Fms

Summary: Selective Aurora A/Flt3 inhibitor

insoluble in H2O; ≥18.75 mg/mL
A3564 Luliconazole

Summary: Azole antifungal agent(interdigital tinea pedis)

insoluble in H2O; ≥17.71 mg/mL
A1047 Angiotensin 1/2 (1-5)

Summary: Vasoconstrictor

insoluble in H2O; ≥66.5 mg/mL
B6128 Fenofibric acid

Summary: ppar inhibitor， lipid-lowering agent

≥31.9 mg/mL